Corbus Pharmaceuticals Holdings News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.02.24	Corbus Pharmaceuticals Names Dominic Smethurst CMO (RTTNews)
31.01.24	Corbus Pharmaceutical Prices Offering Of Approx. 4.3 Mln Shares At $19 Per Share; Stock Up (RTTNews)
31.01.24	Corbus Pharma Announces Proposed Public Offering; Stock Surges (RTTNews)
09.01.24	Corbus Pharma's IND Application Gets FDA Clearance For Anti-avss8 Monoclonal Antibody CRB-601 (RTTNews)
27.09.23	Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting (PR Newswire)
19.09.23	Corbus Pharmaceuticals to Present Pre-Clinical Data Characterizing its CRB-701 Nectin-4 ADC at the at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (PR Newswire)
08.08.23	Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
31.07.23	Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference (PR Newswire)
26.06.23	Corbus Pharmaceuticals Set to Join Russell Microcap® Index (PR Newswire)
31.05.23	Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference (PR Newswire)
09.05.23	Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
01.05.23	Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on CRB-601 avβ8 Blocking Antibody at the New York Academy of Sciences' Frontiers in Cancer Immunotherapy Meeting (PR Newswire)
18.04.23	Corbus Pharmaceuticals Hosting Virtual 'Meet the Expert' Series: Blocking TGFβ with CRB-601--a New Play for an Old Target (PR Newswire)
17.04.23	Corbus Pharmaceuticals Presents Latest Pre-Clinical Data on CRB-601 at the 2023 American Association for Cancer Research Annual Meeting (PR Newswire)
07.03.23	Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update (PR Newswire)
08.11.22	Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
09.08.22	Corbus Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
10.05.22	Corbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
08.04.22	Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
08.03.22	Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Updates (PR Newswire)
31.01.22	Pre-market Movers: FGI, IMPP, KSCP, WKEY, HAPP… (RTTNews)
07.12.21	Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer (PR Newswire)
12.11.21	Corbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates (PR Newswire)
02.11.21	Pre-market Movers: BAOS, BBLG, DELL, NXTD, CHGG… (RTTNews)
24.06.21	Corbus Says DETERMINE Phase 3 Study Of Lenabasum Did Not Meet Primary Endpoint - Quick Facts (RTTNews)
22.01.21	ADMP's Symjepi Hits Walgreen's Shelves, LLY's Antibody Cuts COVID-19 Risk By 80%, FLDM On Watch (RTTNews)
21.12.20	Pre-market Movers In Healthcare Sector: CBLI, VERO, CRBP, ZOM… (RTTNews)
01.12.20	Pre-market Movers In Healthcare Sector: Moderna, ONTX, CRBP, GENE, OPK… (RTTNews)
08.10.20	Corbus Pharma Announces Restructuring; To Reallocate Capital - Quick Facts (RTTNews)
07.10.20	AXGT Reports Parkinson's Trial Data, CRBP Plunges As Cystic Fibrosis Study Fails, GMDA On Track (RTTNews)
06.10.20	Corbus Pharma Says Phase 2b Study Of Lenabasum Did Not Meet Primary Endpoint - Quick Facts (RTTNews)
05.10.20	Pre-market Movers In Healthcare Sector: ENLV, CHFS, EVGN, SLDB, CTIC, VXRT… (RTTNews)
27.09.20	Week Ahead In Pharma: Clinical Trial Readouts, FDA Decision (ETON, SELB, CRBP…) (RTTNews)
09.09.20	AZN Pauses COVID-19 Vaccine Trial, ALBO Hits New High, CRBP Plunges, PFE To Invest In TRIL (RTTNews)
08.09.20	Corbus Pharma: Lenabasum Phase 3 RESOLVE-1 Trial In SSc Patients Did Not Meet Primary Goal (RTTNews)
08.09.20	Pre-market Movers In Healthcare Sector: ALBO, BIOC, KMDA, BNTX… (RTTNews)
06.09.20	Week Ahead In Pharma: Data Readouts, Results From Interim Analysis, ERS Congress Presentation (RTTNews)
17.08.20	5 Biotech Stocks To Watch In The Coming Weeks (ALBO, ALNY, OTLK, MESO, CRBP) (RTTNews)
21.09.18	ALT Up 514% In 2 Days, CRBP Well Stocked, ACAD Soars On FDA Review (RTTNews)
23.07.18	FDA Nod For AGIO's AML Drug, 2nd Neupogen Biosim Gets Green Light, BGNE On Watch (RTTNews)
09.06.18	An Ear To The Pharma: 8 Stocks To Watch (CMRX, CRBP, KPTI, VRX…) (RTTNews)
30.01.18	ARDM Chokes, ABEO On Track, MASI Gets FDA Nod, ALBO Up 50% YTD (RTTNews)
03.01.18	INSY On A High, KIDS Making Giant Strides, No Stopping APVO, EDIT Uncut (RTTNews)
20.10.17	QURE On Fast Track, Music To CNCE's Ears, CRBP Gets A Facelift, OBLN Deflated (RTTNews)
19.10.17	Corbus Pharmaceutical Holding On To Significant Gain In Afternoon Trading (RTTNews)
11.09.17	Little-Known Biotech Breakthrough Could Save Millions Of Lives (PR Newswire)
08.09.17	NLNK Rallies On Indoximod Data, VRNA Breathes Easy, ALNY Jolted (RTTNews)
07.09.17	Legal and Medical Cannabis Market Investments on the Rise (PR Newswire)
25.08.17	Data on Legal Cannabis Products Show Strong Sales (PR Newswire)
27.07.17	Sector Market Growth in Legalization of Cannabis (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	31.13	2.91 %	K V
Geberit	505.80	2.47 %	K V
ABB	50.70	2.09 %	K V
Holcim	87.22	2.06 %	K V
CieFinRichemont	163.75	1.21 %	K V
Swisscom	512.50	0.10 %	K V
Sonova Hldg	302.60	-0.40 %	K V
Logitech Intl	79.70	-0.62 %	K V
Roche Hldg G	265.40	-1.19 %	K V
Novartis	89.32	-1.40 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Corbus Pharmaceuticals Holdings Inc Registered Shs (Old)

Aktien Top/Flop

Meistgelesene Nachrichten